Johne's disease diagnostics are becoming central to livestock health management as dairy and beef producers, veterinarians, laboratories, and animal health authorities work to control Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of Johne's disease, also known as paratuberculosis. The disease is chronic, progressive, and difficult to eradicate once established in a herd, making early detection, risk-based surveillance, and long-term herd management essential. Diagnostic workflows commonly combine enzyme-linked immunosorbent assay (ELISA), fecal culture, polymerase chain reaction (PCR), environmental sampling, and confirmatory testing to identify infected animals and reduce transmission through manure, colostrum, milk, and contaminated calving environments. Demand for reliable Johne's disease testing is supported by the documented economic burden of reduced milk production, premature culling, lower fertility performance, and compromised animal welfare. Because MAP infection may remain subclinical for years, diagnostics must balance sensitivity, specificity, sampling frequency, herd prevalence, and stage of infection. The strongest diagnostic strategies are therefore not isolated tests but integrated testing programs that combine laboratory evidence with biosecurity, calf management, manure control, risk classification, and veterinary interpretation. As food supply chains place greater emphasis on traceability, antimicrobial stewardship, animal welfare, and preventive herd health, Johne's disease diagnostics are evolving from reactive disease confirmation toward proactive herd-level control and assurance.

Transformative Shifts in the Johne's Disease Diagnostics Landscape

The Johne's disease diagnostics landscape is shifting from occasional animal-level testing toward continuous, data-informed herd surveillance. Traditional fecal culture remains valued for specificity but is slow because MAP is a slow-growing organism, while PCR offers faster detection of MAP DNA and supports more timely decisions on isolation, culling, or management segregation. ELISA continues to play a major role in herd screening due to scalability and practicality, especially when interpreted alongside clinical history and repeated testing. Environmental sampling is gaining relevance for detecting herd-level shedding patterns, particularly in large dairy operations where individual animal sampling can be resource intensive. A major transformation is the movement toward risk-based testing protocols that prioritize high-risk age groups, clinical suspects, purchased animals, and herds with known transmission pathways. Laboratories are also improving sample logistics, digital reporting, quality assurance, and decision-support outputs to help veterinarians translate results into actionable control plans. Another important shift is the growing alignment of diagnostics with farm certification, voluntary control programs, and regional surveillance frameworks. As producers seek to reduce chronic disease losses and improve herd resilience, Johne's disease testing is becoming an embedded component of preventive veterinary services rather than a one-time diagnostic event.

Cumulative Impact of Artificial Intelligence on Johne's Disease Testing

Artificial intelligence is beginning to influence Johne's disease diagnostics by improving how complex herd data are interpreted rather than by replacing established laboratory methods. AI-enabled analytics can combine longitudinal ELISA results, PCR outcomes, milk production records, parity, age, calving history, animal movement data, and clinical observations to flag animals or groups that warrant retesting or management intervention. Machine learning models can support risk stratification in herds where MAP infection is intermittent, subclinical, and difficult to detect through a single diagnostic event. In laboratory operations, AI can assist with workflow optimization, anomaly detection in test results, image or signal interpretation where applicable, and automated quality-control review. For veterinarians and producers, decision-support tools can translate diagnostic data into practical recommendations, such as prioritizing calf management changes, identifying high-risk pens, or refining testing intervals. The cumulative impact of artificial intelligence will be strongest when models are trained on validated datasets, governed by transparent performance metrics, and integrated with veterinary oversight. Given the biological complexity of MAP infection and the consequences of false-positive or false-negative interpretation, AI should be viewed as an augmentation layer that enhances surveillance precision, not as a standalone diagnostic authority.

Key Regional Insights for Johne's Disease Diagnostics

In Asia-Pacific, Johne's disease diagnostics are shaped by rapidly modernizing dairy systems, mixed herd structures, and the need to strengthen laboratory capacity across diverse production environments. Countries with intensive dairy and beef operations are increasingly emphasizing PCR, ELISA, and herd-level screening to support biosecurity and productivity, while smallholder-dominant areas require cost-effective sampling strategies and stronger veterinary outreach. Europe maintains a strong focus on animal welfare, food chain assurance, and coordinated disease control, with many countries using herd classification, targeted testing, and veterinary-supervised control strategies. The European diagnostic landscape is also influenced by stringent laboratory standards, traceability requirements, and cross-border livestock trade considerations. North America has one of the most developed diagnostic ecosystems for Johne's disease, supported by established veterinary laboratory networks, voluntary herd control programs, dairy herd health consulting, and wide use of ELISA, fecal PCR, and environmental testing. The region's emphasis on preventive herd health, milk quality, and traceable livestock movement supports structured MAP surveillance. Latin America presents a varied diagnostic environment, with Brazil and Mexico contributing significant demand due to large cattle populations and expanding dairy and beef production. Adoption is closely tied to veterinary service access, producer awareness, and the ability to integrate MAP testing with broader infectious disease control. Africa faces a more fragmented diagnostic landscape, with demand linked to dairy development programs, imported cattle genetics, and the need to improve surveillance for chronic livestock diseases. Regional progress depends on laboratory infrastructure, affordability, sample transport systems, and integration of Johne's disease diagnostics into broader veterinary public and production health programs. In the Middle East, Johne's disease diagnostics are gaining attention where dairy intensification, imported breeding stock, and high-value herd investments increase the importance of biosecurity screening. Testing adoption is often concentrated in commercial farms and government-supported animal health initiatives.

Key Group Insights for Johne's Disease Diagnostics

Across NATO member countries, many of which overlap with advanced livestock economies in North America and Europe, Johne's disease diagnostics benefit from robust biosecurity cultures, coordinated veterinary systems, and established diagnostic laboratory networks. G7 countries generally demonstrate advanced diagnostic capacity, strong laboratory accreditation practices, and widespread access to veterinary expertise, enabling sophisticated surveillance models that combine serology, molecular testing, environmental sampling, and herd-level risk assessment. BRICS economies bring together some of the world's largest livestock populations and diverse production systems, making Johne's disease diagnostics relevant for productivity protection, genetic improvement programs, and long-term herd resilience. In these countries, diagnostic adoption is strongly connected to scalable testing models, veterinary infrastructure, and modernization of dairy and beef value chains. The European Union supports a more structured environment for MAP diagnostics through harmonized animal health principles, quality-controlled laboratories, and strong emphasis on animal welfare and food system transparency. EU-level trade integration also increases the importance of reliable testing documentation across borders. Within ASEAN, Johne's disease diagnostics are influenced by the coexistence of smallholder dairy farms, commercial livestock operations, and expanding veterinary laboratory networks. Practical testing strategies in the group tend to prioritize affordable screening, producer education, and integration with broader herd health programs. In the GCC, high-value dairy systems, climate-controlled production units, and dependence on imported genetics make disease prevention and entry screening important drivers of Johne's disease testing, particularly where herd biosecurity is a strategic priority. Across these groups, the common trend is the movement from isolated testing toward integrated MAP control programs that connect diagnostics with animal movement controls, calf hygiene, manure management, and producer decision support.

Key Country Insights for Johne's Disease Diagnostics

China is strengthening animal health diagnostics as livestock systems industrialize, with Johne's disease testing becoming more relevant in large dairy operations, herd expansion programs, and imported genetics management. The United States has a mature Johne's disease diagnostics environment supported by extensive veterinary laboratory access, dairy herd health programs, and common use of ELISA, fecal PCR, and environmental sampling in risk-based control plans. Japan is characterized by high biosecurity expectations, advanced laboratory systems, and intensive livestock management, supporting precise diagnostic use in herd health programs. India, with one of the world's largest cattle and buffalo populations, faces a complex diagnostic challenge due to diverse farm sizes, regional veterinary capacity differences, and the need for scalable, affordable screening. Germany combines advanced laboratory capacity with a strong dairy tradition, where diagnostics are increasingly aligned with animal welfare, farm assurance, and biosecurity programs. The United Kingdom emphasizes veterinary-led disease control, quality assurance, and herd health planning, making Johne's disease testing an important tool in dairy management. Australia benefits from a strong veterinary surveillance culture, export-oriented livestock standards, and established biosecurity practices, making Johne's disease diagnostics part of a broader framework for disease risk management and herd assurance. France, Italy, and Spain combine developed laboratory infrastructure with significant dairy and ruminant production, where MAP testing supports herd classification, animal welfare objectives, and preventive veterinary services. South Korea's intensive livestock systems, high traceability expectations, and advanced laboratory capabilities support targeted use of Johne's disease diagnostics in biosecurity-focused herd health programs. Canada shows strong veterinary oversight, producer education, and attention to herd biosecurity in dairy and beef systems, with diagnostic use supported by laboratory access and disease control awareness. Russia's broad geography and mixed production systems create uneven diagnostic access, but large-scale dairy modernization supports demand for structured disease monitoring. Brazil's large dairy and beef industries create significant relevance for MAP surveillance, particularly in commercial herds seeking to improve reproductive performance, milk output, and herd longevity. Mexico's diagnostic adoption is supported by its large cattle sector and growing emphasis on productivity, although access to advanced testing can vary by region and production scale.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated diagnostic programs that combine ELISA, PCR, environmental sampling, and veterinary risk assessment rather than relying on a single test result. Diagnostic providers and laboratories should strengthen assay validation, turnaround time, sample traceability, digital reporting, and interpretive guidance to help producers make timely herd management decisions. Veterinary service organizations should expand producer education on MAP transmission, especially calf exposure, manure contamination, colostrum management, and risks linked to purchasing replacement animals. Livestock operators should implement repeat testing strategies, segregate high-risk animals, improve maternity pen hygiene, avoid feeding pooled colostrum from unverified cows, and align culling decisions with veterinary interpretation. Policymakers and animal health authorities can improve outcomes by supporting voluntary control programs, laboratory quality standards, surveillance coordination, and accessible testing for small and medium-sized farms. Technology developers should focus on decision-support platforms that integrate diagnostic results with farm records while maintaining transparency, data security, and veterinary accountability. Across the value chain, the most effective strategy is to treat Johne's disease diagnostics as part of a continuous control system that links testing frequency, biosecurity, animal movement, and long-term herd improvement.

Research Methodology

This executive summary is developed through a structured secondary research methodology focused on verified veterinary, animal health, diagnostic, and livestock management sources. The approach includes review of peer-reviewed scientific literature on Mycobacterium avium subspecies paratuberculosis, diagnostic test performance, MAP transmission, and herd control strategies. It also considers publicly available guidance from veterinary authorities, agricultural extension programs, animal health organizations, laboratory best-practice references, and disease control frameworks. Insights are synthesized across diagnostic modalities, including ELISA, fecal culture, PCR, environmental sampling, and herd-level surveillance models. Regional, group, and country perspectives are derived from documented differences in livestock production systems, veterinary infrastructure, laboratory capacity, biosecurity practices, and animal health governance. The methodology excludes market sizing, forecasting, and competitive share analysis, focusing instead on evidence-backed industry dynamics, adoption drivers, operational challenges, and practical implications for stakeholders. Content is validated for consistency with established knowledge that Johne's disease is chronic, often subclinical, difficult to eradicate, and best managed through repeated testing combined with biosecurity and herd management controls.

Conclusion

Johne's disease diagnostics are entering a more strategic phase as livestock industries move toward preventive health management, traceability, and data-driven biosecurity. Because MAP infection can remain hidden for long periods and spread through herd environments before clinical signs appear, diagnostic value depends on repeated surveillance, correct test selection, and veterinary interpretation. ELISA, PCR, culture, and environmental sampling each play distinct roles, and the most resilient control programs use these tools in combination with calf hygiene, manure management, animal movement controls, and producer education. Regional adoption varies according to laboratory capacity, herd structure, commercial intensity, and policy support, but the global direction is clear: Johne's disease testing is becoming more integrated, digital, and risk based. Artificial intelligence and advanced analytics can further strengthen surveillance when paired with validated laboratory results and accountable veterinary decision-making. For industry leaders, the opportunity lies in building accessible, reliable, and actionable diagnostic ecosystems that reduce chronic disease losses, improve animal welfare, and support sustainable livestock productivity without overreliance on one-time testing or unverified assumptions.

Product Code: MRR-0D217D5AD843

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Johne's Disease Diagnostics Market, by Animal Type

7.1. Introduction
7.2. Cattle
- 7.2.1. Beef Cattle
- 7.2.2. Dairy Cattle
7.3. Sheep & Goats

8. Johne's Disease Diagnostics Market, by Test Type

8.1. Introduction
8.2. Culture
- 8.2.1. Liquid Media Culture
- 8.2.2. Solid Media Culture
8.3. ELISA
8.4. PCR
8.5. Sequencing-Based Assays
- 8.5.1. Targeted Sequencing Panels
- 8.5.2. Whole-Genome Sequencing

9. Johne's Disease Diagnostics Market, by Sample Type

9.1. Introduction
9.2. Fecal Samples
9.3. Milk Samples
9.4. Tissue Samples

10. Johne's Disease Diagnostics Market, by End User

10.1. Introduction
10.2. Diagnostic Labs
- 10.2.1. Hospital Labs
- 10.2.2. Independent Labs
10.3. Farms
- 10.3.1. Breeding Farms
- 10.3.2. Dairy Farms
10.4. Research Institutes
10.5. Veterinary Clinics

11. Johne's Disease Diagnostics Market, by Distribution Channel

11.1. Introduction
11.2. Offline
11.3. Online

12. Johne's Disease Diagnostics Market, by Region

12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East

13. Johne's Disease Diagnostics Market, by Group

13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC

14. Johne's Disease Diagnostics Market, by Country

14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
- 15.3.1. Concentration Ratio (CR)
- 15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Abcam plc
16.2. Agrolabo S.p.A.
16.3. BBI Solutions OEM Ltd.
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMerieux SA
16.6. BioNote, Inc.
16.7. Biopanda Reagents Ltd.
16.8. Cusabio Technology LLC
16.9. DNA Diagnostic A/S
16.10. Enzo Biochem, Inc.
16.11. FineTest Biotech Co., Ltd.
16.12. Gold Standard Diagnostics Budapest Kft.
16.13. HiMedia Laboratories Pvt. Ltd.
16.14. IDEXX Laboratories, Inc.
16.15. INDICAL BIOSCIENCE GmbH
16.16. Innovative Diagnostics SAS
16.17. LGC Clinical Diagnostics, Inc.
16.18. MV Diagnostics Ltd.
16.19. MyBioSource, Inc.
16.20. Neogen Corporation
16.21. PBD Biotech Ltd.
16.22. Pictor Diagnostics Ltd.
16.23. Promega Corporation
16.24. QIAGEN N.V.
16.25. Randox Laboratories Ltd.
16.26. RayBiotech, Inc.
16.27. Tetracore, Inc.
16.28. Thermo Fisher Scientific Inc.
16.29. VMRD, Inc.
16.30. Zoetis Inc.

Product Code: MRR-0D217D5AD843

LIST OF FIGURES

FIGURE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

TABLE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FECAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FECAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FECAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MILK SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MILK SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MILK SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HOSPITAL LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HOSPITAL LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITAL LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BREEDING FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BREEDING FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BREEDING FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DAIRY FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DAIRY FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DAIRY FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 98. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 104. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 131. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 132. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 134. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 135. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 137. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 153. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 154. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 156. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 157. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 158. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 160. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 161. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 164. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 165. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 166. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 167. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 168. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 169. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 171. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 172. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 175. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 176. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 177. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 178. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 179. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 182. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 183. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 198. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 199. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 200. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 201. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 204. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 208. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 209. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 210. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 211. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 212. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 215. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 216. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 220. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 221. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 223. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 224. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 225. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 227. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 228. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 242. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 243. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 244. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 245. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 246. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 247. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 249. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 250. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 253. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 254. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 255. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 256. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 257. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 258. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 260. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 261. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 264. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 265. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 266. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 267. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 268. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 269. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 271. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 272. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 285. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 286. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 287. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 288. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 289. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 290. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 291. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 293. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 294. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 295. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 297. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 298. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 299. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 300. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 301. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 302. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 304. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 305. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 306. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 307. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 308. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 309. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 310. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 311. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 312. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 313. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 315. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 316. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 317. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 318. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 319. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 320. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 321. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 322. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 323. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 324. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 325. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 326. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 327. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 328. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 330. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 331. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 332. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 333. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
TABLE 334. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 335. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 336. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
TABLE 337. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
TABLE 338. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 339. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 341. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 342. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 343. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
TABLE 344. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SE

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION